Chemoinformaics analysis of Lavandulyl isobutyrate
| Molecular Weight | 224.344 | nRot | 6 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 3 |
| Exact Molecular Weight | 224.178 | nRing | 0 |
| Solubility: LogS | -4.112 | nHRing | 0 |
| Solubility: LogP | 4.645 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 40.987 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.507 |
| Synth | 3.356 |
| Natural Product Likeliness | 1.845 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.047 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.428 |
| MDCK | 0.0000273 |
| BBB | 0.976 |
| PPB | 0.844552 |
| VDSS | 1.898 |
| FU | 0.152013 |
| CYP1A2-inh | 0.603 |
| CYP1A2-sub | 0.173 |
| CYP2c19-inh | 0.277 |
| CYP2c19-sub | 0.897 |
| CYP2c9-inh | 0.072 |
| CYP2c9-sub | 0.474 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.48 |
| CYP3a4-inh | 0.12 |
| CYP3a4-sub | 0.314 |
| CL | 12.255 |
| T12 | 0.274 |
| hERG | 0.018 |
| Ames | 0.014 |
| ROA | 0.027 |
| SkinSen | 0.108 |
| Carcinogencity | 0.288 |
| EI | 0.752 |
| Respiratory | 0.814 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.798139 |